Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Sarcoma 1

Conditions

Leukemia, Myeloid, Acute 186Myelodysplastic Syndromes 82Leukemia 39Leukemia, Myelomonocytic, Chronic 36Recurrence 24Myeloproliferative Disorders 15Congenital Abnormalities 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Lymphoma, Large B-Cell, Diffuse 13Neoplasms 11Primary Myelofibrosis 9Melanoma 9Blast Crisis 9Thrombocythemia, Essential 7Polycythemia Vera 7Leukemia, Myelomonocytic, Acute 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Leukemia, Monocytic, Acute 7Hodgkin Disease 7Carcinoma, Non-Small-Cell Lung 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Ovarian Neoplasms 6Myelodysplastic-Myeloproliferative Diseases 6Anemia, Refractory, with Excess of Blasts 6Neoplasm Metastasis 5Lymphoma 5Leukemia, Myeloid, Accelerated Phase 5Leukemia, Biphenotypic, Acute 5Lymphoma, Non-Hodgkin 4Lung Neoplasms 4

Interventions

Cyclophosphamide 101Etoposide 60Carboplatin 55Vincristine 51Filgrastim 49Topotecan 44Temozolomide 44Melphalan 44Isotretinoin 44Doxorubicin 44Irinotecan 42Cisplatin 353-Iodobenzylguanidine 34Peripheral Blood Stem Cell Transplantation 31dinutuximab 30Granulocyte Colony-Stimulating Factor 30Radiotherapy 29sargramostim 28Granulocyte-Macrophage Colony-Stimulating Factor 25Busulfan 22Magnetic Resonance Spectroscopy 19aldesleukin 18Thiotepa 18fludarabine 17Interleukin-2 17humanized 3F8 anti-GD2 monoclonal antibody 16etoposide phosphate 16naxitamab 15Ifosfamide 15Biopsy 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neuroblastoma × Decitabine × Clear all
NCT01241162 2017-05-09

Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma

University of Louisville

Phase 1 Completed
19 enrolled
CNSSarcoma

Neuroblastoma, Recurrence, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Sarcoma, Synovial

NCT00075634 2013-09-30

Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma

National Cancer Institute (NCI)

Phase 1 Completed
21 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡